Survey of Inhibitors in Plasma-Product Exposed Toddlers
Public ClinicalTrials.gov record NCT01064284. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Inhibitor Development in Previously Untreated Patients (PUPs) or Minimally Blood Component-Treated Patients (MBCTPs) When Exposed to Plasma-derived Von Willebrand Factor-Containing Factor VIII (VWF/FVIII) Concentrates and to Recombinant Factor VIII (rFVIII) Concentrates: An Independent, International, Multicentre, Prospective, Controlled, Randomised, Open Label, Clinical Trial
Study identification
- NCT ID
- NCT01064284
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Fondazione Angelo Bianchi Bonomi
- Other
- Enrollment
- 303 participants
Conditions and interventions
Conditions
Interventions
- PLASMA DERIVED Factor VIII Drug
- Recombinant FVIII Drug
Drug
Eligibility (public fields only)
- Age range
- 1 Minute to 6 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2009
- Primary completion
- Apr 30, 2015
- Completion
- Apr 30, 2015
- Last update posted
- Aug 24, 2017
2010 – 2015
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope National Medical Center | Duarte | California | 91010 | — |
| Children's Hospital Los Angeles (CHLA) | Los Angeles | California | 90027 | — |
| Hemophilia and Thrombosis CenterUniversity of Colorado Denver - Anschutz Aurora | Aurora | Colorado | 80045 | — |
| Rush Hemophilia & Trombophilia Center - Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Louisiana Center for Bleeding and Clotting Disorders, Tulane University Medical Center | New Orleans | Louisiana | 70112 | — |
| University of Mississippi Medical Center, Division of pediatric Hematology/Oncology | Jackson | Mississippi | 39216 | — |
| Children's Mercy Hospital | Kansas City | Missouri | 64108 | — |
| Hemophilia Treatment Center of Las Vegas | Las Vegas | Nevada | 89109 | — |
| MeritCare Roger Maris Cancer Center, Pediatric Oncology | Fargo | North Dakota | 58102 | — |
| Cook Children's Medical Center | Fort Worth | Texas | 76104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01064284, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 24, 2017 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01064284 live on ClinicalTrials.gov.